March 28-29 2018

San Diego, CA



  • PP TN1

    Past Presentations Pack

    Enjoy the following presentations:

    -Memory-Like NK Cells Demonstrate Enhanced Anti-Leukemia Activity in a Xenograft Mouse Model and in Patients with Relapse/Refractory AML

    By Rizwan Romee, Assistant Professor, Division of Oncology, Washington University

    -oNKord® – The First Allogeneic, “Off-the-Shelf” NK Cell Product in Oncology

    By Jan Spanholtz, CSO, Glycostem

    -CMV-induced Adaptive NK Cells and IL-15 Tri-Specific Killer Engagers (TriKEs) Mediate Enhanced CD16 Signaling for Targeted Cancer Therapy

    By Jeffrey Miller, Professor of Medicine, University of Minnesota

  • Survey

    Innate Killer Survey Results 2017

    Download to see the full report from this year’s survey

  • Post-Event-Report2-192x300

    Post Event Report

    Download to see the full report of the event

  • Survey-thumb1

    Innate Killer Survey Results 2016

    Download to see the full report of the survey results